S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
Chick-fil-A Is Hiring an 'Entertainment Producer'
All the trading advice you’ve ever received boils down to this (Ad)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
Chick-fil-A Is Hiring an 'Entertainment Producer'
All the trading advice you’ve ever received boils down to this (Ad)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
Chick-fil-A Is Hiring an 'Entertainment Producer'
All the trading advice you’ve ever received boils down to this (Ad)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
Chick-fil-A Is Hiring an 'Entertainment Producer'
All the trading advice you’ve ever received boils down to this (Ad)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections

DMK Pharmaceuticals Stock Price, News & Analysis (NASDAQ:DMK)

$0.57
+0.03 (+5.58%)
(As of 12/1/2023 ET)
Compare
Today's Range
$0.50
$0.57
50-Day Range
$0.48
$0.77
52-Week Range
$0.45
$21.70
Volume
125,040 shs
Average Volume
122,174 shs
Market Capitalization
$5.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

DMK stock logo

About DMK Pharmaceuticals Stock (NASDAQ:DMK)

DMK Pharmaceuticals Corporation, a clinical stage neuro-biotechnology company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory diseases. The company's lead clinical stage product candidate, DPI-125, which is indicated for the treatment of opioid use disorder. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company was formerly known as Adamis Pharmaceuticals Corporation and changed its name to DMK Pharmaceuticals Corporation in September 2023. The company is headquartered in San Diego, California.

DMK Stock Price History

DMK Stock News Headlines

New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Arcimoto, Inc. (FUV)
DMK Pharmaceuticals (NASDAQ:DMK) Trading 2.1% Higher
DMK Pharmaceuticals Corp
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
DMK Pharmaceuticals: Q3 Earnings Snapshot
DMK Pharmaceuticals GAAP EPS of -$0.20
DMK Pharmaceuticals Names Seth Cohen as Finance Chief
DMK Pharmaceuticals Corp.
See More Headlines
Receive DMK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DMK Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/02/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/21/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DMK
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

Net Income
$-26,480,000.00
Net Margins
-630.85%
Pretax Margin
-600.29%

Debt

Sales & Book Value

Annual Sales
$4.76 million
Book Value
($0.52) per share

Miscellaneous

Free Float
9,506,000
Market Cap
$5.73 million
Optionable
Not Optionable
Beta
1.25
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. David J. Marguglio (Age 53)
    Co-Founder, President & COO
    Comp: $526.35k
  • Dr. Ebrahim Versi M.D. (Age 70)
    Ph.D., CEO & Chair of the Board
  • Mr. Seth Abraham Cohen (Age 60)
    Chief Financial Officer
  • Mr. John W. Dorbin Jr. (Age 52)
    General Counsel Corporate Secretary
  • Ms. Jennifer C. Suski
    Senior Director of Marketing
  • Mr. Eddie Wabern Glover (Age 73)
    Chief Executive Officer of US Compounding Inc
  • Mr. Robert B. Rothermel (Age 79)
    Consultant
    Comp: $41.81k














DMK Stock Analysis - Frequently Asked Questions

How have DMK shares performed in 2023?

DMK Pharmaceuticals' stock was trading at $0.6655 on January 1st, 2023. Since then, DMK stock has decreased by 14.7% and is now trading at $0.5677.
View the best growth stocks for 2023 here
.

When is DMK Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 21st 2024.
View our DMK earnings forecast
.

How do I buy shares of DMK Pharmaceuticals?

Shares of DMK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:DMK) was last updated on 12/2/2023 by MarketBeat.com Staff

My Account -